Massaron S - Search Results

1

Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestane.

Martinetti A, Bajetta E, Seregni E, Zilembo N, Ferrari L, Noberasco C, Massaron S, Rimassa L, Bombardieri E. Martinetti A, et al. Among authors: massaron s. Tumour Biol. 1997;18(4):197-205. doi: 10.1159/000218030. Tumour Biol. 1997. PMID: 9218004

2

Mucinous markers in breast cancer.

Seregni E, Botti C, Massaron S, Martinetti A, Ferrari L, Molteni SN, Bombardieri E. Seregni E, et al. Among authors: massaron s. Tumori. 1997 Mar-Apr;83(2):550-1. doi: 10.1177/030089169708300214. Tumori. 1997. PMID: 9226018 Review. No abstract available.

3

P53 accumulation in primary breast cancer: a comparison between immunohistochemistry and a novel luminometric immunoassay.

Bombardieri E, Seregni E, Daidone MG, Benini E, Massaron S, Ferrari L, Di Fronzo G, Silvestrini R. Bombardieri E, et al. Among authors: massaron s. Tumour Biol. 1998;19(1):12-8. doi: 10.1159/000029970. Tumour Biol. 1998. PMID: 9422078

4

Neuron-specific enolase evaluation in patients with neuroblastoma.

Massaron S, Seregni E, Luksch R, Casanova M, Botti C, Ferrari L, Martinetti A, Molteni SN, Bellani FF, Bombardieri E. Massaron S, et al. Tumour Biol. 1998;19(4):261-8. doi: 10.1159/000030016. Tumour Biol. 1998. PMID: 9679736

5

Effects of steroid-free fetal serum and steroid supplementation on MUC1 gene expression in human breast cancer cell line MCF7.

Botti C, Seregni E, Lombardo C, Massaron S, Bombardieri E. Botti C, et al. Among authors: massaron s. Anticancer Res. 1997 Jan-Feb;17(1A):205-8. Anticancer Res. 1997. PMID: 9066652

6

Breast cancer seeking agents: basic approach.

Maffioli L, Seregni E, Nerini Molteni S, Massaron S, Crippa F, Bombardieri E. Maffioli L, et al. Among authors: massaron s. Q J Nucl Med. 1997 Sep;41(3):211-24. Q J Nucl Med. 1997. PMID: 9274129 Review.

7

Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid phase extraction.

Martinetti A, Seregni E, Bajetta E, Bolelli GF, Ferrari L, Massaron S, Botti C, Bombardieri E. Martinetti A, et al. Among authors: massaron s. Int J Biol Markers. 1997 Jul-Sep;12(3):102-5. Int J Biol Markers. 1997. PMID: 9479591

8

S100 protein serum levels in cutaneous malignant melanoma.

Seregni E, Massaron S, Martinetti A, Illeni MT, Rovini D, Belli F, Agresti R, Greco M, Cascinelli N, Bombardieri E. Seregni E, et al. Among authors: massaron s. Oncol Rep. 1998 May-Jun;5(3):601-4. doi: 10.3892/or.5.3.601. Oncol Rep. 1998. PMID: 9538159

9

Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer.

Ferrari L, Bajetta E, Seregni E, Martinetti A, Zilembo N, Noberasco C, Buzzoni R, Botti C, Massaron S, Bichisao E, Celio L, Bombardieri E. Ferrari L, et al. Among authors: massaron s. Int J Oncol. 1997 Jul;11(1):163-7. doi: 10.3892/ijo.11.1.163. Int J Oncol. 1997. PMID: 21528196

10

Reliability of immunoradiometric assays for sex-hormone binding globulin, androstenedione, 17-Beta estradiol and tumor-markers cea and cb15.3 to assess the biological response of megestrol-acetate treatment in patients with advanced breast-cancer.

Botti C, Bogni A, Seregni E, Vicario G, Buzzoni R, Carnaghi C, Celio L, Massaron S, Bombardieri E, Bajetta E. Botti C, et al. Among authors: massaron s. Int J Oncol. 1994 Oct;5(4):881-8. doi: 10.3892/ijo.5.4.881. Int J Oncol. 1994. PMID: 21559656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters